twitter
en ENGLISH
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Bieżący numer Archiwum Filmy Artykuły w druku O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
1/2011
vol. 113
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Opis przypadku

Terapia łączona chirurgiczno-farmakologiczna wysiękowej postaci zwyrodnienia plamki zawiązanego z wiekiem

Małgorzata Figurska
1
,
Jacek Robaszkiewicz
1
,
Agnieszka Bogdan-Bandurska
1

  1. Klinika Okulistyczna Wojskowego Instytutu Medycznego w Warszawie
Klinika Oczna 2011, 113 (1): 56-59
Data publikacji online: 2011/04/17
Pełna treść artykułu Pobierz cytowanie
 
Wstęp
The aim of this paper is to present the early phase of treating exudative age-releted macular degeneration (AMD) – coexisting witch vitreoretinal pathology – with combined pharmacological-surgical therapy.

Materiał i metody
Our observation is based on one clinical case of combined therapy: pars planavitrectomy (PPV) and one intravitrealranibizumab injection. Observation is being carried on larger patient group according to the treatment scheme presented in this paper.

Wyniki
In this case described combined pharmacological-surgical therapy allowed a significant improvement in visual acuity and closure of choroidal neovascularization (CNV), leakage confirmed by fluorescein angiography (FA) and optical coherence tomography (AMD). The treatment is being continued – another ranibizumab injection according to PRONTO study reinjection criteria.

Wnioski
The pathomechanism of exudative AMD and coexistance of vitreoretinal pathology implications confirm reasonability of combined therapy.Due to actual clinical studies: the pharmacological -surgical treatment reduces the number of required intravitreal anti-VEGF agents injections.To confirm this observation we need to perform large randomised clinical studies.



Introduction
The aim of this paper is to present the early phase of treating exudative age-releted macular degeneration (AMD) – coexisting witch vitreoretinal pathology – with combined pharmacological-surgical therapy.

Material and methods
Our observation is based on one clinical case of combined therapy: pars planavitrectomy (PPV) and one intravitrealranibizumab injection. Observation is being carried on larger patient group according to the treatment scheme presented in this paper.

Results
In this case described combined pharmacological-surgical therapy allowed a significant improvement in visual acuity and closure of choroidal neovascularization (CNV), leakage confirmed by fluorescein angiography (FA) and optical coherence tomography (AMD). The treatment is being continued – another ranibizumab injection according to PRONTO study reinjection criteria.

Conclusions
The pathomechanism of exudative AMD and coexistance of vitreoretinal pathology implications confirm reasonability of combined therapy.Due to actual clinical studies: the pharmacological -surgical treatment reduces the number of required intravitreal anti-VEGF agents injections.To confirm this observation we need to perform large randomised clinical studies.

słowa kluczowe:

wysiękowa postać zwyrodnienia plamki związanego z wiekiem (AMD), terapia łączona, witrektomia (PPV), ranibizumab

© 2024 Termedia Sp. z o.o.
Developed by Bentus.